Citation Impact
Citing Papers
Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma
2012 Standout
Chromosome Abnormalities and Genetic Counseling
2011
A monocyte/macrophage antigen recognized by the four antibodies GHI/61, Ber-MAC3, Ki-M8 and SM4.
1992
Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapy
2003
Amplification of oncogenes in human cancer cells
1998
ROS stress in cancer cells and therapeutic implications
2004 Standout
Sepsis biomarkers: a review
2010 Standout
Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy
2009
B7‐H1 expression is regulated by MEK/ERK signaling pathway in anaplastic large cell lymphoma and Hodgkin lymphoma
2009
Immunohistochemical monitoring of plasmacytoid cells in lymph node sections of Kikuchi-Fujimoto disease by a new pan-macrophage antibody Ki-M1P
1992
TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors
2000 Standout
Mammalian phosphoinositide kinases and phosphatases
2009 StandoutNobel
Anaplastic lymphoma kinase proteins in growth control and cancer
2004
Inflammatory Myofibroblastic Tumor
2007 Standout
Cancer drug resistance: an evolving paradigm
2013 Standout
Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancer
2007 StandoutNature
Enigmatic Kikuchi-Fujimoto Disease A Comprehensive Review
2004 Standout
Inflammatory myofibroblastic tumours: where are we now?
2007 Standout
Neuroblastoma: biological insights into a clinical enigma
2003 Standout
Identification of NPM-ALK interacting proteins by tandem mass spectrometry
2004
WHO-EORTC classification for cutaneous lymphomas
2005 Standout
Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria
2004 Standout
Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumor
2010 Standout
Assessment of t(2;5)(p23;q35) Translocation and Variants in Pediatric ALK+ Anaplastic Large Cell Lymphoma
2004
Mimicking white matter tract topography using core–shell electrospun nanofibers to examine migration of malignant brain tumors
2013
Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T‐cell or null cell phenotype
1993
CD30/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group.
1995
Overexpression of the amplified Pip4k2β gene from 17q11–12 in breast cancer cells confers proliferation advantage
2003
Oncogene amplification in solid tumors
1999
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
Identification of the haemoglobin scavenger receptor
2001 StandoutNature
Neuroblastoma
2007 Standout
Smallest region of overlapping deletion in 1p36 in human neuroblastoma: A 1 Mbp cosmid and PAC contig
2001
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
The STATs of cancer — new molecular targets come of age
2004 Standout
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
2003 Standout
Health Supervision for Children With Down Syndrome
2011 Standout
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
MYC oncogenes and human neoplastic disease
1999
Natural History and Biology of Stage A Neuroblastoma: A Pediatric Oncology Group Study
2000
Erythropoietin and renin as biological markers in critically ill patients
2004
STATs: transcriptional control and biological impact
2002 Standout
PVF2, a PDGF/VEGF‐like growth factor, induces hemocyte proliferation in Drosophila larvae
2002 StandoutNobel
t(1;2)(q21;p23) and t(2;3)(p23;q21): Two Novel Variant Translocations of the t(2;5)(p23;q35) in Anaplastic Large Cell Lymphoma
1999
The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
2008
Detection of t(2;5)(p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis.
1996
Electrospinning and Electrospun Nanofibers: Methods, Materials, and Applications
2019 Standout
The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements.
1997
Role of the Nucleophosmin (NPM) Portion of the Non-Hodgkin’s Lymphoma-Associated NPM-Anaplastic Lymphoma Kinase Fusion Protein in Oncogenesis
1997
EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer.
1997 Standout
Prognostic Significance of Anaplastic Lymphoma Kinase (ALK) Protein Expression in Adults With Anaplastic Large Cell Lymphoma
1999
Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry
2002
Tyrosine kinase oncogenes in normal hematopoiesis and hematological disease
2002
Hypoxia-Inducible Factor 1 and Dysregulated c-Myc Cooperatively Induce Vascular Endothelial Growth Factor and Metabolic Switches Hexokinase 2 and Pyruvate Dehydrogenase Kinase 1
2007 StandoutNobel
Ki-1—positive anaplastic large-cell lymphoma can mimic benign dermatoses
1993
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Multilevel Dysregulation of STAT3 Activation in Anaplastic Lymphoma Kinase-Positive T/Null-Cell Lymphoma
2002
Prognostic Significance of Anaplastic Lymphoma Kinase (ALK) Protein Expression in Adults With Anaplastic Large Cell Lymphoma
1999
A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma
2003
Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity
1995
ALK-Positive Lymphoma: A Single Disease With a Broad Spectrum of Morphology
1998
Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.
1998
Frequent expression of the NPM-ALK chimeric fusion protein in anaplastic large-cell lymphoma, lympho-histiocytic type.
1997
A new variant anaplastic lymphoma kinase (ALK)-fusion protein (ATIC-ALK) in a case of ALK-positive anaplastic large cell lymphoma.
2000
CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy
1995
A New Fusion Gene TPM3-ALK in Anaplastic Large Cell Lymphoma Created by a (1;2)(q25;p23) Translocation
1999
Detection of Anaplastic Lymphoma Kinase (ALK) and Nucleolar Protein Nucleophosmin (NPM)-ALK Proteins in Normal and Neoplastic Cells With the Monoclonal Antibody ALK1
1997
ALK+ lymphoma: clinico-pathological findings and outcome.
1999
High rate of CAD gene amplification in human cells deficient in MLH1 or MSH6
2001 StandoutNobel
Biologic Variables in the Outcome of Stages I and II Neuroblastoma Treated With Surgery as Primary Therapy: A Children’s Cancer Group Study
2000
A New Fusion Gene TPM3-ALK in Anaplastic Large Cell Lymphoma Created by a (1;2)(q25;p23) Translocation
1999
Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's Lymphoma
1994 StandoutScience
Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like)
2000
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
2008 Standout
Lymphomas expressing ALK fusion protein(s) other than NPM-ALK.
1999
Works of J.P. Vannier being referenced
CD30‐positive large cell lymphomas (‘Ki‐1 lymphoma’) are associated with a chromosomal translocation involving 5q35
1990
N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
1997
Erythropoietin Blood Level Is Increased in Sudden Infant Death
1999
Collagens, stromal cell‐derived factor‐1α and basic fibroblast growth factor increase cancer cell invasiveness in a hyaluronan hydrogel
2008
Fertility preservation in adolescent males: experience over 22 years at Rouen University Hospital
2008
Molecular monitoring of tumor cell contamination in leukapheresis products from stage IV neuroblastoma patients before and after positive CD34 selection
1998